Taiji Yoshino
Astellas Pharma
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Taiji Yoshino.
Journal of Immunology | 2003
Jun Ishikawa; Keiko Ohga; Taiji Yoshino; Ryuichi Takezawa; Atsushi Ichikawa; Hirokazu Kubota; Toshimitsu Yamada
In nonexcitable cells, Ca2+ entry is mediated predominantly through the store depletion-dependent Ca2+ channels called store-operated Ca2+ (SOC) or Ca2+ release-activated Ca2+ channels. YM-58483, a pyrazole derivative, inhibited an anti-CD3 mAb-induced sustained Ca2+ influx in acute T cell leukemia, Jurkat cells. But it did not affect an anti-CD3 mAb-induced transient intracellular Ca2+ increase in Ca2+-free medium, nor anti-CD3 mAb-induced phosphorylation of phospholipase Cγ1. It was suggested that YM-58483 inhibited Ca2+ influx through SOC channels without affecting the TCR signal transduction cascade. Furthermore, YM-58483 inhibited thapsigargin-induced sustained Ca2+ influx with an IC50 value of 100 nM without affecting membrane potential. YM-58483 inhibited by 30-fold the Ca2+ influx through SOC channels compared with voltage-operated Ca2+ channels, while econazole inhibited both SOC channels and voltage-operated Ca2+ channels with an equivalent range of IC50 values. YM-58483 potently inhibited IL-2 production and NF-AT-driven promoter activity, but not AP-1-driven promoter activity in Jurkat cells. Moreover, this compound inhibited delayed-type hypersensitivity in mice with an ED50 of 1.1 mg/kg. Therefore, we concluded that YM-58483 was a novel store-operated Ca2+ entry blocker and a potent immunomodulator, and could be useful for the treatment of autoimmune diseases and chronic inflammation. Furthermore, YM-58483 would be a candidate for the study of capacitative Ca2+ entry mechanisms through SOC/CRAC channels and for identification of putative Ca2+ channel genes.
Luts: Lower Urinary Tract Symptoms | 2016
Ryoko Kurihara; Kenichiro Ishizu; Hajime Takamatsu; Taiji Yoshino; Noriyuki Masuda
We investigated the relaxant effect of stimulation of prostaglandin E2 (PGE2) receptor subtype EP2 as well as the involvement of a cyclic AMP (cAMP)‐dependent pathway related to stimulation of EP2 receptors in urethral function in rats by evaluating effects of PGE2 and selective EP2 receptor agonist CP‐533,536.
Luts: Lower Urinary Tract Symptoms | 2016
Ryoko Kurihara; Katsunori Imazumi; Hajime Takamatsu; Kenichiro Ishizu; Taiji Yoshino; Noriyuki Masuda
We investigated the effect of the selective prostaglandin E2 EP2 receptor agonist CP‐533,536 on voiding efficiency in rats with midodrine‐induced functional urethral obstruction.
Luts: Lower Urinary Tract Symptoms | 2018
Kenichiro Fujimoto; Taiji Yoshino; Katsuro Yoshioka; Hironori Yuyama; Noriyuki Masuda; Masahiro Takeda
To clarify the role of bradykinin in urogenital pain, we investigated bradykinin involvement in rat models of testicular pain.
Luts: Lower Urinary Tract Symptoms | 2017
Kenichiro Fujimoto; Taiji Yoshino; Satoko Nakajima; Hironori Yuyama; Noriyuki Masuda; Masahiro Takeda
We investigated the role of bradykinin in urethral function by examining contractile responses in urethral smooth muscle strips isolated from humans and the intraurethral pressure in rats and dogs.
European Journal of Pharmacology | 2007
Taiji Yoshino; Jun Ishikawa; Keiko Ohga; Tatsuaki Morokata; Ryuichi Takezawa; Hiroki Morio; Youhei Okada; Kazuo Honda; Toshimitsu Yamada
Bioorganic & Medicinal Chemistry | 2008
Yasuhiro Yonetoku; Hirokazu Kubota; Yoji Miyazaki; Yoshinori Okamoto; Masashi Funatsu; Noriko Yoshimura-Ishikawa; Jun Ishikawa; Taiji Yoshino; Makoto Takeuchi; Mitsuaki Ohta
Pulmonary Pharmacology & Therapeutics | 2008
Keiko Ohga; Ryuichi Takezawa; Taiji Yoshino; Toshimitsu Yamada; Yasuaki Shimizu; Jun Ishikawa
European Journal of Pharmacology | 2005
Masahiro Noguchi; Aishi Kimoto; Seiji Kobayashi; Taiji Yoshino; Keiji Miyata; Masao Sasamata
European Journal of Pharmacology | 2005
Masanori Suzuki; Akiyoshi Ohtake; Taiji Yoshino; Hironori Yuyama; Aska Hayashi; Masashi Ukai; Hiroko Okutsu; Yukiko Noguchi; Shuichi Sato; Masao Sasamata